Gene · 4486
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer. | Mol Oncol | 2022 | 34919788 | PubTator, text mining | PubMed |
| DNA-PKcs: A Targetable Protumorigenic Protein Kinase. | Cancer Res | 2022 | 34893509 | PubTator, text mining | PubMed |
| Impacts and mechanisms of alternative mRNA splicing in cancer metabolism, immune response, and therapeutics. | Mol Ther | 2022 | 34793975 | PubTator, text mining | PubMed |
| Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis. | Ann Rheum Dis | 2022 | 34750102 | PubTator, text mining | PubMed |
| Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35. | Oncogene | 2022 | 34743208 | PubTator, text mining | PubMed |
| Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology. | Cancer Metastasis Rev | 2022 | 34716856 | PubTator, text mining | PubMed |
| Evolving cancer-niche interactions and therapeutic targets during bone metastasis. | Nat Rev Cancer | 2022 | 34611349 | PubTator, text mining | PubMed |
| The inability to belch syndrome: A study using concurrent high-resolution manometry and impedance monitoring. | Neurogastroenterol Motil | 2022 | 34435723 | PubTator, text mining | PubMed |
| Arginine methylation in the epithelial-to-mesenchymal transition. | FEBS J | 2022 | 34358413 | PubTator, text mining | PubMed |
| An insight into lung cancer: a comprehensive review exploring ALK TKI and mechanisms of resistance. | Bosn J Basic Med Sci | 2022 | 34082691 | PubTator, text mining | PubMed |
| LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor. | Semin Cancer Biol | 2022 | 33476721 | PubTator, text mining | PubMed |
| Ligand-based Discovery of Novel Small Molecule Inhibitors of RON Receptor Tyrosine Kinase. | Mol Inform | 2022 | 33274845 | PubTator, text mining | PubMed |
| An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases. | Front Pharmacol | 2021 | 35153741 | PubTator, text mining | PubMed |
Disease progression and pseudoprogression following partial response with rare gingiva metastasis upon IBI308 (sintilimab) immunotherapy reflects the complexity of metastatic lung cancer: a case report. | Transl Cancer Res | 2021 | 35116284 | PubTator, text mining | PubMed |
| Kinase Function of Brassinosteroid Receptor Specified by Two Allosterically Regulated Subdomains. | Front Plant Sci | 2021 | 35095975 | PubTator, text mining | PubMed |
| Insights on Cancer Cell Inhibition, Subcellular Activities, and Kinase Profile of Phenylacetamides Pending 1H-Imidazol-5-One Variants. | Front Pharmacol | 2021 | 35069208 | PubTator, text mining | PubMed |
| High Level of Staufen1 Expression Confers Longer Recurrence Free Survival to Non-Small Cell Lung Cancer Patients by Promoting THBS1 mRNA Degradation. | Int J Mol Sci | 2021 | 35008641 | PubTator, text mining | PubMed |
| Ribosomal Protein S6: A Potential Therapeutic Target against Cancer? | Int J Mol Sci | 2021 | 35008473 | PubTator, text mining | PubMed |
| Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer. | Front Immunol | 2021 | 34992609 | PubTator, text mining | PubMed |
| The Placental Innate Immune System Is Altered in Early-Onset Preeclampsia, but Not in Late-Onset Preeclampsia. | Front Immunol | 2021 | 34992598 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4486/papers?page=20